AR126445A2 - Metodo para preparar inhibidores de btk - Google Patents
Metodo para preparar inhibidores de btkInfo
- Publication number
- AR126445A2 AR126445A2 ARP220101839A ARP220101839A AR126445A2 AR 126445 A2 AR126445 A2 AR 126445A2 AR P220101839 A ARP220101839 A AR P220101839A AR P220101839 A ARP220101839 A AR P220101839A AR 126445 A2 AR126445 A2 AR 126445A2
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- mixture
- reaction mixture
- reaction products
- reaction
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229940124291 BTK inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 17
- 239000011541 reaction mixture Substances 0.000 abstract 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 4
- 239000007795 chemical reaction product Substances 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 239000002904 solvent Substances 0.000 abstract 3
- 239000003054 catalyst Substances 0.000 abstract 2
- 229910052763 palladium Inorganic materials 0.000 abstract 2
- 125000003172 aldehyde group Chemical group 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
- B01J31/2414—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom comprising aliphatic or saturated rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Reivindicación 1: Un método para preparar compuesto (200), sus estereoisómeros, sus isómeros geométricos, sus tautómeros y sus sales, estando el método caracterizado porque comprende: (i) (1) formar una primera mezcla de reacción que comprende compuesto (170), compuesto (181), un catalizador de paladio, un sistema disolvente que comprende agua, y una base, en donde la relación de volumen de solvente a peso de compuesto (170) en la mezcla de reacción es menos que 20:1 litros por kg, la proporción de equivalentes de compuesto (181) a compuesto (170) es más que 1:1, y la proporción de equivalentes del catalizador de paladio a compuesto (170) es de aproximadamente 0,005:1 a aproximadamente 0,05:1, (2) hacer reaccionar la primera mezcla de reacción para formar una primera mezcla de productos de reacción que comprende compuesto (190) de acuerdo con el siguiente esquema: [1], y (3) aislar compuesto (190) de la primera mezcla de productos de reacción; y (ii) (1) formar una segunda mezcla de reacción que comprende compuesto (190), un agente reductor, una base y un solvente, (2) hacer reaccionar la segunda mezcla de reacción para reducir el grupo aldehído del compuesto (190) y formar una segunda mezcla de productos de reacción que comprende compuesto (200), y (3) aislar compuesto (200) de la segunda mezcla de productos de reacción, en donde el rendimiento de compuesto (190) es por lo menos 50% en base al compuesto (170), y el rendimiento de compuesto (200) es por lo menos 50% en base al compuesto (190).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662434569P | 2016-12-15 | 2016-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126445A2 true AR126445A2 (es) | 2023-10-11 |
Family
ID=61007648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170103487A AR110357A1 (es) | 2016-12-15 | 2017-12-13 | Proceso para preparar inhibidores de btk |
| ARP220101839A AR126445A2 (es) | 2016-12-15 | 2022-07-13 | Metodo para preparar inhibidores de btk |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170103487A AR110357A1 (es) | 2016-12-15 | 2017-12-13 | Proceso para preparar inhibidores de btk |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US10385058B2 (es) |
| EP (2) | EP3825317A3 (es) |
| JP (2) | JP6800334B2 (es) |
| KR (2) | KR102375771B1 (es) |
| CN (2) | CN111333656B (es) |
| AR (2) | AR110357A1 (es) |
| AU (4) | AU2017376580B2 (es) |
| BR (1) | BR112019011247A2 (es) |
| CA (2) | CA3104116A1 (es) |
| ES (1) | ES2894262T3 (es) |
| HR (1) | HRP20211553T1 (es) |
| IL (2) | IL284690B (es) |
| MX (2) | MX2019005527A (es) |
| PL (1) | PL3555099T3 (es) |
| SG (2) | SG10202009148XA (es) |
| SI (1) | SI3555099T1 (es) |
| TW (3) | TWI766176B (es) |
| WO (1) | WO2018109050A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018109050A1 (en) | 2016-12-15 | 2018-06-21 | F. Hoffmann-La Roche Ag | Process for preparing btk inhibitors |
| US11100492B2 (en) * | 2018-02-19 | 2021-08-24 | Peter Garrett | General purpose re-loadable card aggregation implementation |
| US20210221792A1 (en) * | 2020-01-16 | 2021-07-22 | Hanmi Pharm Co., Ltd. | Convergent synthesis of poziotinib derivative |
| WO2021164735A1 (en) | 2020-02-20 | 2021-08-26 | Hutchison Medipharma Limited | Heteroaryl heterocyclic compounds and uses thereof |
| CN115715291A (zh) * | 2020-06-18 | 2023-02-24 | 上海华汇拓医药科技有限公司 | 布鲁顿酪氨酸激酶抑制剂及其制备方法 |
| TW202220998A (zh) | 2020-09-21 | 2022-06-01 | 大陸商和記黃埔醫藥（上海）有限公司 | 雜芳基雜環化合物及其用途 |
| WO2022206924A1 (zh) * | 2021-04-02 | 2022-10-06 | 南京明德新药研发有限公司 | 含氮三并环双功能化合物及其制备方法和应用 |
| JP2024517004A (ja) | 2021-05-05 | 2024-04-18 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | Ｂｔｋ阻害剤を調製するための方法 |
| CN113603685A (zh) * | 2021-07-23 | 2021-11-05 | 都创(上海)医药开发有限公司 | Fenebrutinib化合物的晶型及其制备方法和用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3431541A1 (de) * | 1984-08-28 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung |
| US7432375B2 (en) * | 2003-03-06 | 2008-10-07 | Eisai R & D Management Co., Ltd. | JNK inhibitors |
| EP1865959A2 (en) * | 2005-03-25 | 2007-12-19 | Glaxo Group Limited | Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives |
| EP2197552B1 (en) * | 2007-09-19 | 2012-11-21 | 4Sc Ag | Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| US8440830B2 (en) | 2007-09-19 | 2013-05-14 | 4Sc Ag | Tetrahydro-fused pyridines as histone deacetylase inhibitors |
| CN101781312B (zh) * | 2009-12-30 | 2012-09-26 | 中国科学院广州生物医药与健康研究院 | 一种吲哚衍生物的合成方法 |
| AU2011249912A1 (en) * | 2010-05-07 | 2012-11-29 | Genentech, Inc. | Pyridone and aza-pyridone compounds and methods of use |
| AR088642A1 (es) * | 2011-11-03 | 2014-06-25 | Genentech Inc | Compuestos de piperazina alquilados |
| CA2852964A1 (en) * | 2011-11-03 | 2013-05-10 | F. Hoffmann-La Roche Ag | Bicyclic piperazine compounds |
| UA111756C2 (uk) * | 2011-11-03 | 2016-06-10 | Ф. Хоффманн-Ля Рош Аг | Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона |
| US9076830B2 (en) * | 2011-11-03 | 2015-07-07 | Applied Materials, Inc. | Robot systems and apparatus adapted to transport dual substrates in electronic device manufacturing with wrist drive motors mounted to upper arm |
| US8703953B2 (en) * | 2012-03-09 | 2014-04-22 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
| TW201427970A (zh) * | 2012-10-12 | 2014-07-16 | Univ Health Network | 激酶抑制劑及使用其治療癌症的方法 |
| JP6410790B2 (ja) * | 2013-03-14 | 2018-10-24 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ミトコンドリアアルデヒドデヒドロゲナーゼ−２調節因子およびその使用方法 |
| TWI513371B (zh) * | 2013-07-08 | 2015-12-11 | Lextar Electronics Corp | 整合無線暨有線的照明控制系統 |
| JP6275846B2 (ja) * | 2013-12-05 | 2018-02-07 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 求電子性官能基を有するヘテロアリールピリドン及びアザ−ピリドン化合物 |
| TWI659019B (zh) * | 2014-02-28 | 2019-05-11 | 日商帝人製藥股份有限公司 | 吡唑醯胺衍生物 |
| DE102015206627A1 (de) | 2014-07-09 | 2016-01-28 | Siemens Aktiengesellschaft | Selbstsichernder Umrichter |
| CN111303159A (zh) * | 2014-10-02 | 2020-06-19 | 豪夫迈·罗氏有限公司 | 用于治疗由布鲁顿酪氨酸激酶(btk)介导的疾病的吡唑甲酰胺化合物 |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| PT3233103T (pt) | 2014-12-18 | 2021-01-18 | Principia Biopharma Inc | Tratamento de pênfigo |
| CN107973791B (zh) * | 2015-04-29 | 2020-04-07 | 南京圣和药业股份有限公司 | 稠环或三环芳基嘧啶化合物用作激酶抑制剂 |
| JP6577143B2 (ja) * | 2016-02-29 | 2019-09-18 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ブルトンチロシンキナーゼの阻害剤を含む剤形組成物 |
| WO2018109050A1 (en) | 2016-12-15 | 2018-06-21 | F. Hoffmann-La Roche Ag | Process for preparing btk inhibitors |
-
2017
- 2017-12-13 WO PCT/EP2017/082723 patent/WO2018109050A1/en unknown
- 2017-12-13 SG SG10202009148XA patent/SG10202009148XA/en unknown
- 2017-12-13 SI SI201730936T patent/SI3555099T1/sl unknown
- 2017-12-13 AU AU2017376580A patent/AU2017376580B2/en active Active
- 2017-12-13 AR ARP170103487A patent/AR110357A1/es unknown
- 2017-12-13 JP JP2019528485A patent/JP6800334B2/ja active Active
- 2017-12-13 TW TW108126347A patent/TWI766176B/zh active
- 2017-12-13 MX MX2019005527A patent/MX2019005527A/es unknown
- 2017-12-13 TW TW106143737A patent/TWI673271B/zh active
- 2017-12-13 IL IL284690A patent/IL284690B/en unknown
- 2017-12-13 KR KR1020207037471A patent/KR102375771B1/ko active IP Right Grant
- 2017-12-13 CN CN202010294389.0A patent/CN111333656B/zh active Active
- 2017-12-13 EP EP20189072.0A patent/EP3825317A3/en active Pending
- 2017-12-13 CA CA3104116A patent/CA3104116A1/en active Pending
- 2017-12-13 ES ES17832491T patent/ES2894262T3/es active Active
- 2017-12-13 SG SG10201913918UA patent/SG10201913918UA/en unknown
- 2017-12-13 CA CA3039090A patent/CA3039090C/en active Active
- 2017-12-13 CN CN201780076739.2A patent/CN110446710B/zh active Active
- 2017-12-13 PL PL17832491T patent/PL3555099T3/pl unknown
- 2017-12-13 KR KR1020197016973A patent/KR102257159B1/ko active IP Right Grant
- 2017-12-13 HR HRP20211553TT patent/HRP20211553T1/hr unknown
- 2017-12-13 BR BR112019011247A patent/BR112019011247A2/pt active Search and Examination
- 2017-12-13 EP EP17832491.9A patent/EP3555099B1/en active Active
- 2017-12-13 MX MX2020012097A patent/MX2020012097A/es unknown
- 2017-12-13 TW TW108126350A patent/TW201940489A/zh unknown
- 2017-12-14 US US15/841,828 patent/US10385058B2/en active Active
-
2019
- 2019-02-26 IL IL265067A patent/IL265067B/en unknown
- 2019-07-02 US US16/460,889 patent/US10882864B2/en active Active
-
2020
- 2020-02-21 AU AU2020201260A patent/AU2020201260B2/en active Active
- 2020-02-21 AU AU2020201261A patent/AU2020201261B2/en active Active
- 2020-11-23 US US17/102,086 patent/US11661424B2/en active Active
- 2020-11-24 JP JP2020194373A patent/JP7153705B2/ja active Active
-
2021
- 2021-02-18 AU AU2021201052A patent/AU2021201052A1/en not_active Abandoned
-
2022
- 2022-07-13 AR ARP220101839A patent/AR126445A2/es unknown
-
2023
- 2023-04-12 US US18/299,622 patent/US20230250103A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR126445A2 (es) | Metodo para preparar inhibidores de btk | |
| ES2520091T3 (es) | Método para preparar alfa-olefinas lineales | |
| AR110461A1 (es) | Proceso para preparar una mezcla de alcoholes de terpeno | |
| BR112013031103A2 (pt) | síntese de derivados de 7-acetileno quinonametídeo e sua aplicação como retardadores da polimerização de vinilícos | |
| AR076027A1 (es) | Metodos e intermediarios para la preparacion de agentes farmaceuticos | |
| AR088296A1 (es) | Citramida de rasagilina, proceso de preparación y composicion farmaceutica | |
| PE20100487A1 (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable | |
| AR107494A1 (es) | Proceso para la preparación de osimertinib (azd9291) o una sal del mismo, y azd9291 anilina o una sal de la misma | |
| AR077526A1 (es) | Metodo para la sintesis de (1s,2r)- milnacipran | |
| JP2016538335A5 (es) | ||
| MX2019013003A (es) | Disociacion de un complejo de 1,4-bis(4-fenoxibenzoil)benceno-acid o de lewis en una solucion acuosa. | |
| AR109669A1 (es) | Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano | |
| KR20170027855A (ko) | 사이클로헥사논의 제조를 위한 방법 및 시스템 | |
| BR112018010229A2 (pt) | sistema catalisador e processo para a produção de glicóis | |
| JP2016520038A5 (es) | ||
| AR084864A1 (es) | Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso | |
| MX2018002031A (es) | Proceso para la preparacion de 1,4-bis (etoximetil) ciclohexano. | |
| BR112018010230A2 (pt) | sistema catalisador e processo para a produção de glicóis | |
| AR112461A1 (es) | PROCESOS PARA LA PRODUCCIÓN DE SALES Y FORMAS CRISTALINAS DE INHIBIDORES DE RORg | |
| BR112020023769B1 (pt) | Processo de preparação de compostos de ciclopropano usando compostos diazo | |
| AR087345A1 (es) | Metodos para la preparacion de compuestos de tiofeno | |
| CO2021001857A2 (es) | Preparación de intermedio útil para la síntesis de inhibidor de sglt | |
| AR099705A1 (es) | Sistema y método para producir hidrógeno | |
| CL2019002795A1 (es) | Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano. | |
| ES2723437T3 (es) | Procesos y productos intermedios para la preparación de un inhibidor de PDE10 |